UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment of pancreatic β-cell function: review of methods and clinical applications

Current diabetes reviews, 2014-01, Vol.10 (1), p.2-42

2014

Volltextzugriff (PDF)

Understanding the kidneys' role in blood glucose regulation

The American journal of managed care, 2012-01, Vol.18 (1 Suppl), p.S11-S16

Triplitt, Curtis L

2012

Volltextzugriff (PDF)

Examining the mechanisms of glucose regulation

The American journal of managed care, 2012-01, Vol.18 (1 Suppl), p.S4-10

Triplitt, Curtis L

2012

Volltextzugriff (PDF)

Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists

American journal of health-system pharmacy, 2021-03, Vol.78 (7), p.556-567

2021

Volltextzugriff (PDF)

Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients

Diabetes, obesity & metabolism, 2017-06, Vol.19 (6), p.809-813

2017

Volltextzugriff (PDF)

Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy

Diabetes (New York, N.Y.), 2018-06, Vol.67 (6), p.1182-1189

2018

Volltextzugriff (PDF)

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors

Diabetes (New York, N.Y.), 2020-04, Vol.69 (4), p.681-688

2020

Volltextzugriff (PDF)

New technologies and therapies in the management of diabetes

The American journal of managed care, 2007-04, Vol.13 Suppl 2, p.S47-S54

Triplitt, Curtis L

2007

Volltextzugriff (PDF)

Effect of weight-maintaining ketogenic diet on glycemic control and insulin sensitivity in obese T2D subjects

BMJ open diabetes research & care, 2024-10, Vol.12 (5), p.e004199

2024

Volltextzugriff (PDF)

Nephropathy in Youth and Young Adults with Type 2 Diabetes

Current diabetes reports, 2014-02, Vol.14 (2), p.456-456, Article 456

2014

Volltextzugriff (PDF)

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus

American journal of physiology: endocrinology and metabolism, 2002-12, Vol.283 (6), p.E1135-E1143

2002

Volltextzugriff (PDF)

Physiological and Molecular Determinants of Insulin Action in the Baboon

Diabetes (New York, N.Y.), 2008-04, Vol.57 (4), p.899-908

2008

Volltextzugriff (PDF)

Addition of Pioglitazone and Ramipril to Intensive Insulin Therapy in Type 2 Diabetic Patients Improves Vascular Dysfunction by Different Mechanisms

Diabetes care, 2008, Vol.31 (1), p.121-127

2008

Volltextzugriff (PDF)

Inhibition of renal glucose reabsorption as a novel treatment for diabetes patients

Brazilian Journal of Nephrology, 2014-01, Vol.36 (1), p.80-92

2014

Volltextzugriff (PDF)

Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment

Vascular health and risk management, 2010-01, Vol.6 (default), p.671-690

2010

Volltextzugriff (PDF)

Improving treatment success rates for type 2 diabetes: recommendations for a changing environment

The American journal of managed care, 2010-08, Vol.16 (7 Suppl), p.S195-S200

Triplitt, Curtis

2010

Volltextzugriff (PDF)

Non‐steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes

Diabetes, obesity & metabolism, 2024-02, Vol.26 (2), p.417-430

2024

Volltextzugriff (PDF)

Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus

The journal of clinical endocrinology and metabolism, 2018-04, Vol.103 (4), p.1402-1407

2018

Volltextzugriff (PDF)

Dose-Response Effect of a Single Administration of Oral Hexyl-Insulin Monoconjugate 2 in Healthy Nondiabetic Subjects

Diabetes care, 2004-12, Vol.27 (12), p.2868-2873

2004

Volltextzugriff (PDF)

Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT

Diabetes care, 2021-02, Vol.44 (2), p.433-439

2021

Volltextzugriff (PDF)

Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist

Advances in therapy, 2019-05, Vol.36 (5), p.1031-1051

2019

Volltextzugriff (PDF)

Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea

Diabetes care, 2006-11, Vol.29 (11), p.2371-2377

2006

Volltextzugriff (PDF)

Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study

Hepatology (Baltimore, Md.), 2016-12, Vol.64 (6), p.2028-2037

2016

Volltextzugriff (PDF)

Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes

Diabetes (New York, N.Y.), 2017-07, Vol.66 (7), p.1999-2006

2017

Volltextzugriff (PDF)

Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose

Diabetes care, 2022-06, Vol.45 (6), p.1372-1380

2022

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

Humans
(43)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Diabetes Mellitus, Type 2 - Drug Therapy
(35)
Endocrinology & Metabolism
(27)
Male
(23)
Diabetes
(22)
Female
(21)
Hypoglycemic Agents - Therapeutic Use
(20)
Middle Aged
(18)
Blood Glucose - Metabolism
(16)
Glucose
(16)
Diabetes Mellitus
(15)
Insulin
(15)
Diabetes Mellitus, Type 2 - Blood
(12)
Insulin Resistance
(12)
Diabetes Mellitus, Type 2 - Metabolism
(11)
Drug Therapy, Combination
(10)
Glucose - Metabolism
(9)
Glucose Clamp Technique
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessment of pancreatic β-cell function: review of methods and clinical applications

Understanding the kidneys' role in blood glucose regulation

Examining the mechanisms of glucose regulation

Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists

Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients

Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors

New technologies and therapies in the management of diabetes

Effect of weight-maintaining ketogenic diet on glycemic control and insulin sensitivity in obese T2D subjects

Nephropathy in Youth and Young Adults with Type 2 Diabetes

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus

Physiological and Molecular Determinants of Insulin Action in the Baboon

Addition of Pioglitazone and Ramipril to Intensive Insulin Therapy in Type 2 Diabetic Patients Improves Vascular Dysfunction by Different Mechanisms

Inhibition of renal glucose reabsorption as a novel treatment for diabetes patients

Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment

Improving treatment success rates for type 2 diabetes: recommendations for a changing environment

Non‐steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes

Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus

Dose-Response Effect of a Single Administration of Oral Hexyl-Insulin Monoconjugate 2 in Healthy Nondiabetic Subjects

Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT

Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist

Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea

Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study

Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes

Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose

Aktive Filter

Suchergebnisse filtern